Cargando…
P1148: REAL WORLD DATA (RWD) AMONG FOLLICULAR LYMPHOMA (FL) PATIENTS IN GERMANY WITH AT LEAST TWO PRIOR LINES OF SYSTEMIC THERAPY AND COMPARISON WITH CLINICAL DATA FOR MOSUNETUZUMAB
Autores principales: | Marschner, N., Hanselmann, J., McGough, S., Braun, S., Pfizler-Dempfle, S., Sandner, R., Mohm, J., Jaber, M., Hamm, D., Hamm, N., Jaenicke, M., Shewade, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430647/ http://dx.doi.org/10.1097/01.HS9.0000847460.08152.b3 |
Ejemplares similares
-
Multiple Real-World Data Sources in a Bayesian Framework to Inform Long-Term Survival Estimates of Mosunetuzumab in Patients with Follicular Lymphoma
por: Sanchez Alvarez, Javier, et al.
Publicado: (2023) -
RWD-Cockpit: Application for Quality Assessment of Real-world Data
por: Babrak, Lmar Marie, et al.
Publicado: (2022) -
Survival analysis of 1148 women diagnosed with breast cancer in Southern Iran
por: Rezaianzadeh, Abbas, et al.
Publicado: (2009) -
RWD61 Analysis of the National Database of the Russian Federation on the Safety of Medicines for Etiopathogenetic Treatment covid-19 in Clinical Practice (REAL-WORLD DATA; RWD)
por: Kolbin, A, et al.
Publicado: (2022) -
Mosunetuzumab and lymphoma: latest updates from 2022 ASH annual meeting
por: Cao, Yang, et al.
Publicado: (2023)